Sign In
Sign Up
Two Blokes
BioCryst Pharmaceuticals (BCRX) Reports Break-Even Earnings for Q1
click to rate
Posted by
Two Blokes
May 5
- Filed in
Stock
- 3 views
BioCryst Pharmaceuticals (BCRX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago.
